Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tennis elbow indication sought for OssaTron:

This article was originally published in Clinica

Executive Summary

HealthTronics Surgical Services has move to expand the US market for its shock wave device by submitting a premarket approval application to the FDA to use the product as a treatment for tennis elbow. The OssaTron device uses high-energy shock waves to cause microscopic damage to the scar tissue that forms in the elbow as a result of the condition. The therapy leads to the growth of new blood vessels in the area and allows tissue-healing cells to repair the chronic injury, says the Marietta, Georgia firm, which sells the device in the US for treating plantar fasciitis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074255

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel